Is the P-value Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?

Kus, TulayAktas, GokmenCicin, Irfan2024-06-122024-06-1220231083-71591549-490Xhttps://doi.org/10.1093/oncolo/oyad145https://hdl.handle.net/20.500.14551/25777This commentary asks if, when determining the target P-value in a clinical study, it is sufficient to evaluate the study as negative or positive based on the target P-value alone, or whether this could lead to illusions.en10.1093/oncolo/oyad145info:eu-repo/semantics/openAccess[No Keywords]Is the P-value Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?EditorialN/AWOS:0010037046000012-s2.0-8517504699937294662Q1